ResMed Inc. (RMD.AX)
| Previous close | 23.04 |
| Open | 22.99 |
| Bid | 22.84 x 51100 |
| Ask | 22.90 x 25600 |
| Day's range | 22.82 - 23.04 |
| 52-week range | 21.25 - 36.37 |
| Volume | |
| Avg. volume | 3,574,136 |
| Market cap | 33.647B |
| Beta (5Y monthly) | 0.52 |
| PE ratio (TTM) | 24.56 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.30 (1.26%) |
| Ex-dividend date | 16 Aug 2023 |
| 1y target est | N/A |
- Zacks
Here's Why Investors Should Retain ResMed (RMD) Stock for Now
Investors continue to be optimistic about ResMed (RMD) due to the core business' performance and sustained growth in the SaaS business.
- Bloomberg
Weight-Loss Drugs Divide Wall Street on Medical Device Stocks
(Bloomberg) -- With weight-loss drugs that reduce the risk of heart attacks and diabetes potentially improving millions of lives, stock investors have had the somewhat unpleasant task of sussing out the impact on a host of health-care companies.Most Read from BloombergOnce Unthinkable Bond Yields Now the New Normal For MarketsCongress Averts US Government Shutdown Hours Before DeadlineMcCarthy to Face Far-Right Attempt to Oust Him as House SpeakerSenate Voting on Bill to Avert US Government Shut
- Zacks
ResMed (RMD) Stock Jumps 3.8%: Will It Continue to Soar?
ResMed (RMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
